KARAKTERISTIKE NALAZA NA SCINTIGRAMU ŠTITASTE ŽLEZDE SA 99mTc-PERTEHNETATOM KOD PACIJENATA SA DIFERENCIRANIM TIREOIDNIM KARCINOMOM

  • Katarina D Nikolić Univerzitet u Nišu, Medicinski fakultet
  • Marina Vlajković Univerzitet u Nišu, Medicinski fakultet

Sažetak


Uvod: Diferencirani karcinom štitaste žlezde (DTC), poreklom iz folikularnih ćelija, najučestaliji je endokrini malignitet koji se najčešće javlja kod pacijenata sa tireoidnim nodusima.
Cilj: Cilj ove retrospektivne analize je procena scintigrafskog nalaza štitaste žlezde dobijenog 99mTc-pertehnetatom kod pacijenata sa DTC pre tireoidektomije.
Materijal i metode: Analizom medicinske dokumentacije obuhvaćeno je 95 ispitanika kod kojih je rađena preoperativna evaluacija tireoidnih nodusa. Ukupno je bilo 18 muška­raca (51,5 ± 8,7 godina, rang 43-68 godina) i 77 žena (48 ± 12 godina, rang 14-72 godina). Analizirani su nalazi drugih testova koji su rađeni tokom preoperativnog ispitivanja i to: ultrazvučni pregled štitaste žlezde (EHO) i određivanje koncentracije tireotropina i tireoglobulina.
Rezultati: Od 95 ispitanika sa DTC, kod 20 (21%) je tokom preoperativne evaluacije, pored kliničkog pregleda, urađen EHO štitaste žlezde, dok je kod 75 (79%) urađen i scin tigram 99mTc-pertehnetatom. Kakva je distribucija scintigraskih nalaza? Najveća uče stalost DTC nađena je u polinodoznim strumama, i to kod 61 (64%) ispitanika, dok je kod 31 (33%) ispitanika karcinom nađen u afunkcijskom, “hladnom” nodusu. Najčešći histopatološki nalaz unutar scintigrafski detektovanih afunkcijskih nodusa i polinodozne strume bio je papilarni tireoidni karcinom. Karcinom štitaste žlezde nađen je i kod dvoje ispitanika sa Grejvsovom (Graves) strumom i kod jednog ispitanika sa normalnim scintigrafskim nalazom. Vrednost tireotropnog hormona bila je normalna kod 71% sa DTC i povišena kod manjeg broja (21%). Ultrazvučni pregled je kod samo 18 ispitanika (19%) ukazivao na visokorizične karakteristike nodusa.
Zaključak: Najčešći scintigrafski nalazi kod pacijenata sa dokazanim DTC bili su polinodozna struma i afunkcijski ,,hladni“ nodus. Kod manjeg procenta ispitanika tireoidna neoplazma nađena je kod pacijenata sa hipertireoidizmom. Rezultati studije pokazali su da scintigrafija štitaste žlezde 99mTc-pertehnetatom i dalje ima značajnu dijagnostičku ulogu u ispitivanju tireoidnih nodusa.

Biografija autora

Katarina D Nikolić, Univerzitet u Nišu, Medicinski fakultet

student VI godine integrisanih akademskih studija medicine u Nišu

Reference

Yeung MJ, Serpell JW. Management of the Solitary Thyroid Nodule. The Oncologist 2008;13:105–112.

Jossart GH, Clark OH. Well-differentiated thyroid cancer. Curr Prob Surg 1994; 31:935–1011.

Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328:553–559.

Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998; 8: 377-383.

Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard M, Franklyn JA. Gender, clinical findings and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology. Thyroid 1999; 11:1105-1109.

Bennedbaek FN, Perrild H, Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol 1999;50(3):357-363.

Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.Eur J Nucl Med 2002; 29 (Suppl. 2):425–438.

Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA, Green ED. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A2001;98:4221–4226.

Shimmins J, Alexander WD, McLarty DG, Robertson JWK, Sloane D. 99mTc-pertechnetate for measuring thyroid suppressibility. J Nucl Med 1971; 12:51–54.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodulesand Differentiated Thyroid Cancer. Thyroid 2016; 26(1): 1–133.

Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors formalignancy of thyroid nodules initially identified as follicularneoplasia by fine-needle aspiration: results of a prospective studyof one hundred twenty patients. Thyroid 2000; 10:709–712.

Mackenzie EJ, Mortimer RH. 6: thyroid nodules and thyroid cancer. Med J Aust2004;180(5):242–247.

Wale A,Miles KA, Young B, Zammit C, Williams A, Quin J, Dizdarevic S. Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. Eur J Nucl Med Mol Imaging 2014; 41:105–115.

Paul SJ, Sisson JC. Thyrotoxicosis caused by thyro-id cancer. Endocrinol Metab Clin North Am 1990;19(3):593-612.

David E, Rosen IB, Bain J, James J, Kirsh JC. Management of the hot thyroid nodule. Am J Surg 1995;170(5):481-83.

Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, et al. Thyroid cancer in patients with hyperthyroidism. Horm Res 2003;60:79-83.

Chigot JP, Ménégaux F, Keopadabsy K, Hoang C, Aurengo A, Leenhardt L, et al. Thyroid can-cer in patients with hyperthyroidism. Presse Med 2000;29(36):1969-72.

Als C, Gedeon P, Rösler H, Minder C, Netzer P, Laissue JA. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab 2002;87(9):4122-27.

Iranmanesh P, Pusztaszeri M, Robert J, Meyer P, Schiltz B, Sadowski SM, et al.Thyroid Carcinoma in Hot Nodules: Review of the Literature.World Journal of Endocrine Surgery 2013;5(2):50-54.

Pellegriti G, Mannarino C, Russo M, Terranova R, Marturano I, Vigneri R, et al. Increased mortality in patients with differentiated thyroid cancer associated with Graves’ disease. J Clin Endocrinol Metab 2013;98:1014-1021.

Boostrom S, Richards ML. Total thyroidectomy is the preferred treatment for patients with Graves’ disease and a thyroid nodule. Otolaryngol Head Neck Surg 2007;136:278-281.

Belfiore A, Russo D, Vigneri R, Filetti S. Graves’ disease, thyroid nodules and thyroid cancer. Clin Endocrinol 2001;55:711-718.

Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism. Horm Metab Res 2012;44:255-262.

Objavljeno
2019/06/30
Rubrika
Originalni naučni članak